Theravance, Inc. (NASDAQ: THRX) today announced that the U.S. FDA has posted on its website briefing documents for the November ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE